We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Oral Bacteria Linked to Risk of Intracerebral Hemorrhage

By LabMedica International staff writers
Posted on 09 Mar 2016
Physicians have an increased understanding of patients entering the hospital for acute stroke, and the association between certain types of stroke and the presence of the oral bacteria centronuclear myopathies gene (cnm)-positive Streptococcus mutans.

Small vessel diseases (SVDs) of the brain such as cerebral microbleeds (CMBs), lacunar infarcts, and white matter lesions are important biomarkers of vascular injury and burden of brain dysfunction. More...
The underlying mechanisms and risk factors of the SVDs of the brain are poorly understood.

A team of scientists led by those at the National Cerebral and Cardiovascular Center (NCVC; Osaka, Japan) enrolled patients admitted to the NCVC because of acute heart disease, between February and August 2014, consisting of 67 subjects with ischemic stroke, 5 with transient ischemic attack, and 27 with intracerebral hemorrhage (ICH). The cnm gene in S. mutans isolated from saliva was screened using polymerase chain reaction (PCR) techniques and its collagen-binding activities examined. Oral saliva and dental plaque specimens were collected from the subjects in the first three days following admission.

Oral samples were inoculated on Mitis-Salivarius medium with bacitracin (MSB, 100 U/mL; Sigma-Aldrich; St. Louis, MO, USA) and 15% sucrose (MSB agar) and anaerobically incubated at 37 °C for 48 hours. S. mutans strains were isolated morphologically and all strains were anaerobically grown in brain heart infusion (BHI) broth (Difco Laboratories; Detroit, MI, USA) at 37 °C for 24 hours. DNA of each strain was extracted. S. mutans and cnm gene encoding CBP was screened using polymerase chain reaction techniques. MKD primer32 was used to detect S. mutans and cnm primer was used to identify cnm gene33. A collagen-binding assay with type I collagen was conducted to examine collagen-binding activities of each isolated S. mutans strain.

Eleven cases showed Streptococcus mutans strains positive for cnm. The presence of cnm-positive Streptococcus mutans was significantly associated with ICH and increased number of deep CMBs. In subjects positive for Streptococcus mutans, collagen binding activity was positively correlated with the number of deep CMBs. The authors hypothesize that the S. mutans bacteria may bind to blood vessels weakened by age and high blood pressure, causing arterial ruptures in the brain, leading to small or large hemorrhages.


Robert P. Friedland, MD, a professor of Neurology and co-author of the study, said. “This study shows that oral health is important for brain health. People need to take care of their teeth because it is good for their brain and their heart as well as their teeth. The study and related work in our laboratories have shown that oral bacteria are involved in several kinds of stroke, including brain hemorrhages and strokes that lead to dementia.” The study was published online on February 5, 2016, in the journal Scientific Reports.

Related Links:

National Cerebral and Cardiovascular Center
Sigma-Aldrich
Difco Laboratories 



Gold Member
Veterinary Hematology Analyzer
Exigo H400
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automated PCR Setup
ESTREAM
New
Modular Hemostasis Automation Solution
CN Track
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: Brain biomarkers of Alzheimer\'s disease can be detected as early as middle age (Photo courtesy of University of Shutterstock)

Blood-Based Biomarkers Could Detect Alzheimer's as Early as Middle Age

As the global population ages, Alzheimer's disease and other dementing diseases are becoming more prevalent. The disease processes leading to Alzheimer's symptoms can begin years or even decades before... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: Micrograph showing the distribution of misfolded proteins in myeloma cells (Photo courtesy of Helmholtz Munich)

Novel Method Tracks Cancer Treatment in Cells Without Dyes or Labels

Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.